Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ISRG vs GSK✓SelectedUSD · GSKISRG vs GSK performance historyLatest closeAs of-1.32%11/16
Stock and ETF performance explorer

ISRG vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+21.2%
GSK return
+46.9%
Excess return
-25.7%
Maximum drawdown
-49.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.3%-0.1%-1.2%-1.3%
7D-5.0%-1.3%-3.6%-4.6%
30D+2.6%+2.7%-0.1%+1.8%
3M+11.0%+2.7%+8.2%+10.1%
6M+3.9%+3.3%+0.6%+3.1%
YTD-22.7%+6.5%-29.2%-24.1%
1Y-20.3%+10.7%-31.0%-22.5%
3Y+44.0%+64.4%-20.3%+23.2%
5Y+21.2%+46.7%-25.5%-3.0%
All+21.2%+46.9%-25.7%-3.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling